"To support the UK market development, we have registered PainChek® UK Ltd as a wholly owned subsidiary of PainChek® Ltd and recruited Peter Shergill as the Head of the UK Business Development. Peter starts with PainChek® UK Ltd on 30th September 2019 and he will support the PCS UK sales drive and our direct sales into the UK market including the hospital sector. The UK base will also provide a platform for broader European market expansion in the future."
The Bold Italic I highlighted above is quietly telling us what the plan is for Pete Shergill. With his past experience and connection, this is a great hint to a plan for an NHS funding for hospital use of Painchek. That would be equivalent to our Medicare scheme which I am sure PD is also hoping to achieve here.
Ann: Annual Report to shareholders, page-5
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PCK (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.4¢ |
Change
-0.002(5.56%) |
Mkt cap ! $55.61M | |||
| Open | High | Low | Value | Volume |
| 3.6¢ | 3.7¢ | 3.4¢ | $45.39K | 1.278M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 497311 | 3.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.5¢ | 254838 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| PCK (ASX) Chart |